181 related articles for article (PubMed ID: 19426773)
1. Hypoxia targeting gene expression for breast cancer gene therapy.
Lee M
Adv Drug Deliv Rev; 2009 Aug; 61(10):842-9. PubMed ID: 19426773
[TBL] [Abstract][Full Text] [Related]
2. Development of a hypoxia-responsive vector for tumor-specific gene therapy.
Shibata T; Giaccia AJ; Brown JM
Gene Ther; 2000 Mar; 7(6):493-8. PubMed ID: 10757022
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domain.
Kim HA; Kim K; Kim SW; Lee M
J Control Release; 2007 Aug; 121(3):218-24. PubMed ID: 17628167
[TBL] [Abstract][Full Text] [Related]
5. Hybrid promoters directed tBid gene expression to breast cancer cells by transcriptional targeting.
Farokhimanesh S; Rahbarizadeh F; Rasaee MJ; Kamali A; Mashkani B
Biotechnol Prog; 2010; 26(2):505-11. PubMed ID: 19918914
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy.
Ingram N; Porter CD
Gene Ther; 2005 Jul; 12(13):1058-69. PubMed ID: 15800661
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
Marignol L; Foley R; Southgate TD; Coffey M; Hollywood D; Lawler M
J Gene Med; 2009 Feb; 11(2):169-79. PubMed ID: 19051213
[TBL] [Abstract][Full Text] [Related]
8. Employing tumor hypoxia to enhance oncolytic viral therapy in breast cancer.
Pin RH; Reinblatt M; Fong Y
Surgery; 2004 Aug; 136(2):199-204. PubMed ID: 15300180
[TBL] [Abstract][Full Text] [Related]
9. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia- and radiation-inducible, breast cell-specific targeting of retroviral vectors.
Lipnik K; Greco O; Scott S; Knapp E; Mayrhofer E; Rosenfellner D; Günzburg WH; Salmons B; Hohenadl C
Virology; 2006 May; 349(1):121-33. PubMed ID: 16464484
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
Dorer DE; Nettelbeck DM
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
[TBL] [Abstract][Full Text] [Related]
12. Tumor hypoxia in cancer therapy.
Brown JM
Methods Enzymol; 2007; 435():297-321. PubMed ID: 17998060
[TBL] [Abstract][Full Text] [Related]
13. The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts.
Harada H; Kizaka-Kondoh S; Itasaka S; Shibuya K; Morinibu A; Shinomiya K; Hiraoka M
Biochem Biophys Res Commun; 2007 Sep; 360(4):791-6. PubMed ID: 17624305
[TBL] [Abstract][Full Text] [Related]
14. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
15. Tumor hypoxia and targeted gene therapy.
Greco O; Scott S
Int Rev Cytol; 2007; 257():181-212. PubMed ID: 17280898
[TBL] [Abstract][Full Text] [Related]
16. Imaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells.
Kudo T; Ueda M; Kuge Y; Mukai T; Tanaka S; Masutani M; Kiyono Y; Kizaka-Kondoh S; Hiraoka M; Saji H
J Nucl Med; 2009 Jun; 50(6):942-9. PubMed ID: 19443598
[TBL] [Abstract][Full Text] [Related]
17. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
[TBL] [Abstract][Full Text] [Related]
18. Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors.
Ryan RM; Green J; Williams PJ; Tazzyman S; Hunt S; Harmey JH; Kehoe SC; Lewis CE
Gene Ther; 2009 Mar; 16(3):329-39. PubMed ID: 19177133
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy of brain and endocrine tumors.
Palù G; Bonaguro R; Gnatta E; Franchin E; Barzon L
Croat Med J; 2001 Aug; 42(4):473-7. PubMed ID: 11471203
[TBL] [Abstract][Full Text] [Related]
20. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
Balamurugan K; Luu VD; Kaufmann MR; Hofmann VS; Boysen G; Barth S; Bordoli MR; Stiehl DP; Moch H; Schraml P; Wenger RH; Camenisch G
Oncogene; 2009 Sep; 28(37):3274-85. PubMed ID: 19581925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]